Palisade Bio (PALI) Goodwill & Intangibles (2010 - 2021)
Palisade Bio (PALI) reported Goodwill & Intangibles of $141642.0 for Q1 2021, down 78.2% year-over-year from $649745.0 in Q1 2020, and down 3.73% quarter-over-quarter from $147133.0 in Q4 2020.
Palisade Bio (PALI) Goodwill & Intangibles (2010 - 2021) Analysis & Trends
Palisade Bio (PALI) has 12 years of Goodwill & Intangibles data on file, last reported at $141642.0 in Q1 2021.
- Goodwill & Intangibles for Q1 2021 came in at $141642.0, down 78.2% year-over-year; the trailing twelve-month figure through Mar 2021 was $141642.0 (down 78.2% YoY), and the FY2020 annual result was $147133.0, down 78.0% from the prior year.
- Goodwill & Intangibles eased to $141642.0 in Q1 2021 per PALI's latest filing, from $147133.0 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $945066.0 in Q2 2017 and troughed at $141642.0 in Q1 2021.
- A 5-year average of $669691.8 and a median of $738404.0 in 2019 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2017 and 2021: Goodwill & Intangibles decreased 6.98% in 2017, then tumbled 78.2% in 2021.
- A 5-year view of Goodwill & Intangibles shows it stood at $883462.0 in 2017, then dropped by 13.57% to $763543.0 in 2018, then fell by 12.39% to $668936.0 in 2019, then sank by 78.0% to $147133.0 in 2020, then fell by 3.73% to $141642.0 in 2021.
- Business Quant data shows PALI's Goodwill & Intangibles at $141642.0 in Q1 2021, $147133.0 in Q4 2020, and $152625.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 141,642.00 |
| Dec 31, 2020 | 147,133.00 |
| Sep 30, 2020 | 152,625.00 |
| Jun 30, 2020 | 630,554.00 |
| Mar 31, 2020 | 649,745.00 |
| Dec 31, 2019 | 668,936.00 |
| Sep 30, 2019 | 688,127.00 |
| Jun 30, 2019 | 713,265.00 |
| Mar 31, 2019 | 738,404.00 |
| Dec 31, 2018 | 763,543.00 |
| Sep 30, 2018 | 788,733.00 |
| Jun 30, 2018 | 814,023.00 |
| Mar 31, 2018 | 839,314.00 |
| Dec 31, 2017 | 883,462.00 |
| Sep 30, 2017 | 915,457.00 |
| Jun 30, 2017 | 945,066.00 |
| Mar 31, 2017 | 904,732.00 |
| Dec 31, 2016 | 990,153.00 |
| Sep 30, 2016 | 984,125.00 |
| Jun 30, 2016 | 1.03 Mn |